LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
7.20
+0.55 (8.27%)
At close: May 20, 2026, 4:00 PM EDT
7.09
-0.11 (-1.53%)
After-hours: May 20, 2026, 4:47 PM EDT
LENZ Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, LENZ Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $32. The average 1-year stock price forecast is 344.44% higher than the current stock price, while the lowest is $12 (+66.67%) and the highest is $60 (+733.33%).
Price Target: $32 (+344.44%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LENZ Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $26 → $20 | Strong Buy | Maintains | $26 → $20 | +177.78% | May 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $38 | Strong Buy | Maintains | $48 → $38 | +427.78% | May 12, 2026 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $39 → $12 | Buy → Hold | Downgrades | $39 → $12 | +66.67% | May 12, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $56 → $48 | Strong Buy | Maintains | $56 → $48 | +566.67% | Apr 21, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $52 → $26 | Strong Buy | Maintains | $52 → $26 | +261.11% | Mar 26, 2026 |
Financial Forecast
Revenue This Year
19.42M
from 19.09M
Increased by 1.74%
Revenue Next Year
65.81M
from 19.42M
Increased by 238.87%
EPS This Year
-4.53
from -2.85
EPS Next Year
-3.54
from -4.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 26.1M | 105.0M | ||||||
| Avg | 19.4M | 65.8M | ||||||
| Low | 12.6M | 23.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 36.7% | 440.7% | ||||||
| Avg | 1.7% | 238.9% | ||||||
| Low | -34.0% | 19.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.73 | -1.66 | ||||||
| Avg | -4.53 | -3.54 | ||||||
| Low | -5.45 | -4.99 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.